'Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients'
- PMID: 31302597
- DOI: 10.1136/annrheumdis-2019-215881
'Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients'
Keywords: dmards (biologic); dmards (synthetic); early rheumatoid arthritis; fibroblasts; osteoarthritis.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients' by Buch et al.Ann Rheum Dis. 2020 Nov;79(11):e141. doi: 10.1136/annrheumdis-2019-215903. Epub 2019 Jul 13. Ann Rheum Dis. 2020. PMID: 31302598 No abstract available.
Comment on
-
Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients.Ann Rheum Dis. 2019 Jun;78(6):761-772. doi: 10.1136/annrheumdis-2018-214539. Epub 2019 Mar 16. Ann Rheum Dis. 2019. PMID: 30878974 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical